194 related articles for article (PubMed ID: 1358381)
1. The effects of beta 2-adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes.
Linden M
Br J Pharmacol; 1992 Sep; 107(1):156-60. PubMed ID: 1358381
[TBL] [Abstract][Full Text] [Related]
2. Effects of beta2-agonists and budesonide on interleukin-1beta and leukotriene B4 secretion: studies of human monocytes and alveolar macrophages.
Zetterlund A; Linden M; Larsson K
J Asthma; 1998; 35(7):565-73. PubMed ID: 9777883
[TBL] [Abstract][Full Text] [Related]
3. Budesonide prevents cytokine-induced decrease of the relaxant responses to formoterol and terbutaline, but not to salmeterol, in mouse trachea.
Adner M; Larsson B; Säfholm J; Naya I; Miller-Larsson A
J Pharmacol Exp Ther; 2010 Apr; 333(1):273-80. PubMed ID: 20061444
[TBL] [Abstract][Full Text] [Related]
4. Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages.
Donnelly LE; Tudhope SJ; Fenwick PS; Barnes PJ
Eur Respir J; 2010 Jul; 36(1):178-86. PubMed ID: 19926732
[TBL] [Abstract][Full Text] [Related]
5. Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms.
Cooper PR; Kurten RC; Zhang J; Nicholls DJ; Dainty IA; Panettieri RA
Br J Pharmacol; 2011 Jun; 163(3):521-32. PubMed ID: 21306583
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action.
Holden NS; Rider CF; Bell MJ; Velayudhan J; King EM; Kaur M; Salmon M; Giembycz MA; Newton R
Br J Pharmacol; 2010 May; 160(2):410-20. PubMed ID: 20423350
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
Whelan CJ; Johnson M; Vardey CJ
Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
[TBL] [Abstract][Full Text] [Related]
8. Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.
Lindén A; Bergendal A; Ullman A; Skoogh BE; Löfdahl CG
Thorax; 1993 May; 48(5):547-53. PubMed ID: 8100652
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological similarities and differences between beta2-agonists.
Lötvall J
Respir Med; 2001 Aug; 95 Suppl B():S7-11. PubMed ID: 11534896
[TBL] [Abstract][Full Text] [Related]
10. Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells.
Chu YT; Chang TT; Jong YJ; Kuo PL; Lee HM; Lee MS; Chang HW; Hung CH
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):345-52. PubMed ID: 20003162
[TBL] [Abstract][Full Text] [Related]
11. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
12. Salmeterol is a competitive antagonist at beta-adrenoceptors mediating inhibition of respiratory burst in guinea-pig eosinophils.
Rabe KF; Giembycz MA; Dent G; Perkins RS; Evans P; Barnes PJ
Eur J Pharmacol; 1993 Feb; 231(2):305-8. PubMed ID: 8095902
[TBL] [Abstract][Full Text] [Related]
13. Long acting inhaled beta-adrenoceptor agonists the comparative pharmacology of formoterol and salmeterol.
Anderson GP
Agents Actions Suppl; 1993; 43():253-69. PubMed ID: 8103622
[TBL] [Abstract][Full Text] [Related]
14. Different effects of salmeterol, formoterol and salbutamol on cholinergic responses in the ferret trachea.
Bergendal A; Lindén A; Lötvall J; Skoogh BE; Löfdahl CG
Br J Pharmacol; 1995 Apr; 114(7):1478-82. PubMed ID: 7606351
[TBL] [Abstract][Full Text] [Related]
15. Studies on the interaction between formoterol and salmeterol in guinea-pig trachea in vitro.
Jeppsson AB; Källström BL; Waldeck B
Pharmacol Toxicol; 1992 Oct; 71(4):272-7. PubMed ID: 1360657
[TBL] [Abstract][Full Text] [Related]
16. Beta2-agonists potentiate corticosteroid-induced neutrophil survival.
Perttunen H; Moilanen E; Zhang X; Barnes PJ; Kankaanranta H
COPD; 2008 Jun; 5(3):163-9. PubMed ID: 18568840
[TBL] [Abstract][Full Text] [Related]
17. Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.
Scola AM; Chong LK; Suvarna SK; Chess-Williams R; Peachell PT
Br J Pharmacol; 2004 Jan; 141(1):163-71. PubMed ID: 14662724
[TBL] [Abstract][Full Text] [Related]
18. The effect of salmeterol on human eosinophils is both stimulus- and response-dependent.
Ezeamuzie CI; al-Hage M; Nwankwoala RN
Int J Immunopharmacol; 1997 Aug; 19(8):421-30. PubMed ID: 9568547
[TBL] [Abstract][Full Text] [Related]
19. Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro.
Anderson P; Lötvall J; Lindén A
Lung; 1996; 174(3):159-70. PubMed ID: 8830192
[TBL] [Abstract][Full Text] [Related]
20. Effects of beta2 adrenoceptor agonists on T-cell subpopulations.
Holen E; Elsayed S
APMIS; 1998 Sep; 106(9):849-57. PubMed ID: 9808411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
